Boxer Capital as of June 30, 2019
Portfolio Holdings for Boxer Capital
Boxer Capital holds 35 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Mirati Therapeutics | 15.5 | $177M | 1.7M | 103.00 | |
Odonate Therapeutics Ord | 10.8 | $123M | 3.4M | 36.69 | |
Beigene (BGNE) | 9.8 | $112M | 900k | 123.95 | |
Immunomedics | 8.0 | $91M | 6.6M | 13.87 | |
Spark Therapeutics | 5.4 | $61M | 600k | 102.38 | |
Uniqure Nv (QURE) | 4.2 | $48M | 615k | 78.15 | |
Esperion Therapeutics (ESPR) | 4.0 | $45M | 975k | 46.52 | |
Ptc Therapeutics I (PTCT) | 3.9 | $45M | 1.0M | 45.00 | |
Dbv Technologies S A (DBVT) | 3.8 | $44M | 5.3M | 8.22 | |
Gossamer Bio (GOSS) | 3.6 | $42M | 1.9M | 22.18 | |
Atreca Inc Cl A (BCEL) | 2.9 | $33M | 1.7M | 18.84 | |
Milestone Pharmaceuticals (MIST) | 2.6 | $30M | 1.1M | 27.15 | |
Amicus Therapeutics (FOLD) | 2.5 | $29M | 2.3M | 12.48 | |
Argenx Se (ARGX) | 2.5 | $28M | 200k | 141.58 | |
Medicines Company | 2.4 | $27M | 750k | 36.47 | |
Wave Life Sciences (WVE) | 2.3 | $26M | 1.0M | 26.09 | |
Rocket Pharmaceuticals (RCKT) | 1.9 | $22M | 1.5M | 15.00 | |
Allakos (ALLK) | 1.8 | $21M | 475k | 43.33 | |
Solid Biosciences | 1.8 | $20M | 3.5M | 5.75 | |
Kura Oncology (KURA) | 1.4 | $17M | 845k | 19.69 | |
Prevail Therapeutics Ord | 1.3 | $15M | 1.1M | 13.20 | |
Global Blood Therapeutics In | 1.1 | $13M | 250k | 52.60 | |
Cymabay Therapeutics | 0.8 | $9.0M | 1.3M | 7.16 | |
Matinas Biopharma Holdings, In (MTNB) | 0.8 | $8.8M | 10M | 0.86 | |
Mersana Therapeutics (MRSN) | 0.7 | $8.4M | 2.1M | 4.05 | |
Ideaya Biosciences (IDYA) | 0.7 | $7.6M | 764k | 9.96 | |
Kadmon Hldgs | 0.7 | $7.6M | 3.7M | 2.06 | |
Akero Therapeutics (AKRO) | 0.7 | $7.6M | 397k | 19.15 | |
Mei Pharma | 0.6 | $7.3M | 2.9M | 2.50 | |
La Jolla Pharmaceuticl Com Par | 0.5 | $5.3M | 575k | 9.25 | |
Kalvista Pharmaceuticals (KALV) | 0.4 | $4.4M | 200k | 22.15 | |
Kiniksa Pharmaceuticals (KNSA) | 0.3 | $3.9M | 291k | 13.54 | |
Voyager Therapeutics (VYGR) | 0.2 | $2.7M | 100k | 27.22 | |
Cellectar Biosciences | 0.2 | $2.0M | 920k | 2.18 | |
Novus Therapeutics | 0.0 | $328k | 324k | 1.01 |